<DOC>
	<DOC>NCT01712451</DOC>
	<brief_summary>Dose ranging study</brief_summary>
	<brief_title>Dose-ranging Study</brief_title>
	<detailed_description />
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>18 45 years of age inclusive abdominal contour defect BMI &lt;25 kg/msq Stable diet and exercise and body weight Prior treatment of abdominal contour defects (liposuction, abdominoplasty, etc) Known hypersensitivity to study drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>adiposity</keyword>
</DOC>